Sitosterolemia susceptibility gene (SSG): compositions and methods of use
View Patent ↗The present invention provides nucleic acids encoding a novel ABC family cholesterol transporter, SSG. The herein-disclosed sequences can be used for any of a number of purposes, including for the diagnosis and treatment of cholesterol-associated disorders, including sitosterolemia, and for the identification of molecules that associate with and/or modulate the activity of SSG.
1. An isolated nucleic acid encoding an ATP-binding cassette (ABC) family sterol transporter polypeptide, said polypeptide comprising an amino acid sequence that is at least 95% identical to the full-length of an amino acid sequence as set forth in SEQ ID NO:3, wherein said nucleic acid hybridizes under stringent hybridization conditions comprising 50% formamide, 5×SSC, 1% SDS at 65° C. and wash conditions of 0.2×SSC, 0.1% SDS at 65° C. to a nucleic acid comprising a nucleotide sequence as set forth in SEQ ID NO:4, and where said amino acid sequence comprises an ATP-binding cassette (ABC) family sterol transporter.
2. The nucleic acid of claim 1 , wherein said polypeptide specifically binds to monoclonal antibodies generated against a polypeptide that comprises an amino acid sequence as set forth in SEQ ID NO:3.
3. The nucleic acid of claim 1 , wherein said polypeptide comprises an amino acid sequence as set forth in SEQ ID NO:3.
4. The nucleic acid of claim 1 , wherein said polypeptide forms a dimer with a second ABC polypeptide, and wherein said dimer has sterol transport activity.
5. The nucleic acid of claim 4 , wherein said dimer is a heterodimer.
6. The nucleic acid of claim 4 , wherein said sterol is cholesterol.
7. The nucleic acid of claim 5 , wherein said second ABC polypeptide is ATP-Binding Cassette 8 (ABC8).
8. The nucleic acid of claim 1 , wherein said nucleic acid comprises a nucleotide sequence as set forth in SEQ ID NO:4.
9. The nucleic acid of claim 1 , wherein said nucleic acid is form a mouse or a human.
10. The nucleic acid of claim 1 , wherein said nucleic acid is expressed in the intestine or in the liver in the presence of a liver X receptor (LXR) agonist.
11. The nucleic acid of claim 1 , wherein said nucleic acid is expressed in a tissue selected from the group consisting of liver, jejunum, ileum, and duodenum.
12. An expression cassette comprising the nucleic acid of claim 1 operably linked to a promoter.
13. An isolated cell tranformed with the expression cassette of claim 12 .
14. A method of making an ABC family sterol transporter polypeptide, the method comprising:
(i) introducing a nucleic acid of claim 1 into a host cell or cellular extract; and
(ii) incubating said host cell or cellular extract under conditions such that said ABC family sterol transporter polypeptide is expressed in the host cell or cellular extract.
15. The method of claim 14 , further comprising recovering the SSG polypeptide from the host cell or cellular extract.
16. An isolated nucleic acid encoding an ATP-binding cassette (ABC) family sterol transporter polypeptide, said polypeptide comprising an amino acid sequence that is at least 95% identical to the full-length of an amino acid sequence as set forth in SEQ ID NO:3, and wherein said amino acid sequence comprises an ATP-binding cassette (ABC) family sterol transporter.
17. An isolated nucleic acid encoding an ATP-binding cassette (ABC) family sterol transporter polypeptide, wherein said nucleic acid comprises a nucleotide sequence at least 95% identical to the full-length of a sequence as set forth in SEQ ID NO:4.
18. An isolated nucleic acid encoding an ATP-binding cassette (ABC) family sterol transporter polypeptide, wherein said polypeptide comprises an amino acid sequence as set forth in SEQ ID NO:3.
19. An isolated nucleic acid encoding an ATP-binding cassette (ABC) family sterol transporter polypeptide, wherein said nucleic acid comprises a nucleotide sequence as set forth in SEQ ID NO:4.